|  |  | Recurrence-free survival in cN0M0 cases | |||
---|---|---|---|---|---|---|
Variable | Unfavorable/favorable characteristics | No. of Patients | Analysis | Relative risk | 95% confidential interval | P value |
p-SUVmax* | high/low | 26/26 | Univariate (U) | 14.361 | 4.283 - 64.472 | 0.00940 |
Multivariate (M) | 1.714 | 0.021 - 142.351 | 0.64270 | |||
pAkt (Ser473) | high/low | 26/26 | U | 5.895 | 1.688 - 50.514 | 0.03910 |
M | 2.374 | 0.062 - 367.647 | 0.78520 | |||
pAkt (Thr308) | high/low | 25/27 | U | 5.321 | 1.621 - 45.612 | 0.04810 |
 | 2.157 | 0.069 - 397.026 | 0.79130 | |||
pS6 | high/low | 26/26 | U | 3.994 | 0.466 - 34.272 | 0.12190 |
M | Â | Â | Â | |||
Grade | 4/3/2/1 | 2/13/28/9 | U | 11.397 | 3.320 - 33.119 | 0.00007 |
M | 31.171 | 1.836 - 529.228 | 0.01730 | |||
pT | 4,3/2,1 | 13/39 | U | 7.807 | 1.920 - 31.753 | 0.00410 |
M | 5.151 | 0.187 - 151.279 | 0.15370 | |||
v | 1/0 | 24/28 | U | 4.941 | 1.016 - 24.035 | 0.04780 |
M | 2.355 | 0.156 - 35.559 | 0.53630 | |||
cell type | sarcomatoid/non-cc/cc* | 3/9/40 | U | 7.051 | 2.634 - 18.876 | 0.00010 |
M | 1.029 | 0.091 - 11.577 | 0.78180 |